IMGN Financial Facts
Research and development: 32.91MResearch and development support: 1.35M
See Full Income Statement
Accounts receivable: 316K
Accounts payable: 8.97M
See Full Balance Sheet
Immunogen Inc. (IMGN) Earnings
|
Expand Research on IMGN
| Next EPS Date | 4/25/24 *Est. | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +73.5% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +51.9% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
1/27/11  |
 |
Q211 | -$0.21 | -$0.22 | +$0.01 | $4.2M | $4.07M | N/A |  | | Details |
| 4/28/23 | Q123 | -$0.16 | -$0.25 | +$0.09 | $49.9M | $20.97M | N/A | | | Details | |
| 11/1/19 | |
Q319 | -$0.15 | -$0.18 | +$0.03 | $13.28M | $9.88M | = | | | Details |
| 5/3/19 | |
Q119 | -$0.30 | -$0.20 | -$0.10 | $8.6M | $10.59M | = | | | Details |
| 8/2/19 | |
Q219 | -$0.29 | -$0.33 | +$0.04 | $15.54M | $9.48M | = | | | Details |
| 2/9/18 | |
Q417 | -$0.11 | -$0.12 | +$0.01 | $39.45M | $32.71M | = | | | Details |
| 1/30/15 |
|
Q215 | $0.16 | -$0.05 | +$0.21 | $48.3M | $37.3M | N/A | | | Details |
| 2/12/21 | |
Q420 | $0.16 | -$0.10 | +$0.26 | $85.8M | $37.09M | = | | | Details |
